Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 17.88
  • Annual Dividend & Yield 0.14 (0.14%)
  • Most Recent Dividend 0.015 on 09/23/24
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 23.44% ( -6.41%)
  • Historical Volatility 17.17%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 38.19% on 08/05/24
  • IV Low 23.44% on 11/06/24
  • Put/Call Vol Ratio 0.97
  • Today's Volume 107,718
  • Volume Avg (30-Day) 47,493
  • Put/Call OI Ratio 1.26
  • Today's Open Interest 891,869
  • Open Int (30-Day) 874,270

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.08 +7.74%
on 10/10/24
103.31 -0.84%
on 11/06/24
+4.93 (+5.06%)
since 10/04/24
3-Month
92.12 +11.20%
on 08/07/24
103.52 -1.04%
on 09/19/24
+8.00 (+8.47%)
since 08/06/24
52-Week
64.99 +57.62%
on 11/13/23
103.52 -1.04%
on 09/19/24
+32.56 (+46.59%)
since 11/06/23

Most Recent Stories

More News
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Small biotech firms like Cassava Sciences, INmune Bio, and Annovis Bio are developing innovative Alzheimer’s treatments, disrupting big pharma’s dominance in the $13.7B market. For those targeting...

ANVS : 8.58 (+3.13%)
LLY : 776.38 (-3.68%)
INMB : 6.43 (+3.88%)
XBI : 102.44 (+1.81%)
BIIB : 174.40 (-1.43%)
SAVA : 26.57 (+11.03%)
Exact Sciences Stock Plunges After Q3 Miss, Guidance Cut: Retail Stays Mostly Positive

Wall Street analysts cut price targets for Exact Sciences stock but retail sees the weakness as buying opportunity.

EXAS : 54.72 (-23.48%)
VB : 250.76 (+4.12%)
XBI : 102.44 (+1.81%)
Moderna Stock Slips On Report Of CEO Relinquishing Sales Chief Role: Retail Mood Dims

Moderna's COVID-19 vaccine windfall is now a thing of the past as it struggles to shore up revenue and reverse to a profit.

IBB : 146.60 (+1.06%)
MRNA : 51.81 (-2.78%)
SPY : 591.04 (+2.49%)
XBI : 102.44 (+1.81%)
ETF Strategies to Realize the Halloween Effect This Year

It may sound ironic, but the occasion of ghouls and ghosts can turn into an occasion of angels for Wall Street. Yes, it’s the Halloween Effect that normally lights up Wall Street. As you start carving...

C : 69.03 (+8.42%)
XLV : 148.04 (+0.13%)
BAC : 45.41 (+8.43%)
JPM : 247.06 (+11.54%)
PSI : 57.61 (+3.37%)
TDV : 78.45 (+3.18%)
GS : 595.98 (+13.10%)
SPSM : 48.40 (+6.05%)
IYF : 114.52 (+6.85%)
VIOO : 115.19 (+6.01%)
IAT : 55.06 (+11.41%)
XSW : 180.08 (+5.95%)
Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?

After more than doubling in the past year, is this clinical-stage biotech stock still a buy?

CRBP : 18.91 (-1.25%)
$SPX : 5,929.04 (+2.53%)
NVO : 105.36 (-4.33%)
MRK : 100.73 (-0.91%)
LLY : 776.38 (-3.68%)
ABBV : 201.20 (-0.24%)
PFE : 27.36 (-2.25%)
XBI : 102.44 (+1.81%)
BMY : 55.28 (-1.20%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 8.58 (+3.13%)
LLY : 776.38 (-3.68%)
INMB : 6.43 (+3.88%)
XBI : 102.44 (+1.81%)
BIIB : 174.40 (-1.43%)
SAVA : 26.57 (+11.03%)
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

IBB : 146.60 (+1.06%)
GILD : 91.69 (+1.63%)
XBI : 102.44 (+1.81%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

REGN : 816.65 (-1.54%)
GILD : 91.69 (+1.63%)
IBB : 146.60 (+1.06%)
XBI : 102.44 (+1.81%)
SBIO : 40.94 (+3.99%)
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.

The Federal Reserve's fight against inflation may soon yield financial benefits.

XBI : 102.44 (+1.81%)
VKTX : 65.87 (+1.92%)
IOVA : 12.14 (+4.12%)
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target

The SPDR S&P Biotech ETF (XBI)  is an exchange-traded fund that tracks the biotechnology segment of the S&P Total Market Index. This ETF allows investors to gain exposure to large, mid, and small-cap...

XBI : 102.44 (+1.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 106.14
2nd Resistance Point 104.73
1st Resistance Point 103.58
Last Price 102.44
1st Support Level 101.02
2nd Support Level 99.61
3rd Support Level 98.46

See More

52-Week High 103.52
Last Price 102.44
Fibonacci 61.8% 88.80
Fibonacci 50% 84.25
Fibonacci 38.2% 79.71
52-Week Low 64.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar